1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 64 F.Supp.3d
  5. 64 F.Supp.3d 665 (2014)
 

IN RE SUBOXONE

MDL No. 2445, 13-MD-2445.

64 F.Supp.3d 665 (2014)

In re SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION. This Document Applies to: All Actions.

United States District Court, E.D. Pennsylvania.

Signed December 3, 2014.

MEMORANDUM OPINION

This multidistrict litigation raises the following question: can a pharmaceutical company marketing brand-name prescription drugs be subject to antitrust liability for engaging in what has been referred to as a "product hopping" scheme...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases